Cargando…
Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti‐programmed death receptor ligand 1 therapy response of triple‐negative breast cancer
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352603/ https://www.ncbi.nlm.nih.gov/pubmed/37461253 http://dx.doi.org/10.1002/ctm2.1335 |
| _version_ | 1785074542314520576 |
|---|---|
| author | Chen, Xi Yan, Yuanliang Liu, Wangrui Liu, Yuanhong Thakur, Abhimanyu Liang, Qiuju Xu, Zhijie |
| author_facet | Chen, Xi Yan, Yuanliang Liu, Wangrui Liu, Yuanhong Thakur, Abhimanyu Liang, Qiuju Xu, Zhijie |
| author_sort | Chen, Xi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10352603 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103526032023-07-19 Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti‐programmed death receptor ligand 1 therapy response of triple‐negative breast cancer Chen, Xi Yan, Yuanliang Liu, Wangrui Liu, Yuanhong Thakur, Abhimanyu Liang, Qiuju Xu, Zhijie Clin Transl Med Letter to the Editor John Wiley and Sons Inc. 2023-07-17 /pmc/articles/PMC10352603/ /pubmed/37461253 http://dx.doi.org/10.1002/ctm2.1335 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Chen, Xi Yan, Yuanliang Liu, Wangrui Liu, Yuanhong Thakur, Abhimanyu Liang, Qiuju Xu, Zhijie Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti‐programmed death receptor ligand 1 therapy response of triple‐negative breast cancer |
| title | Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti‐programmed death receptor ligand 1 therapy response of triple‐negative breast cancer |
| title_full | Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti‐programmed death receptor ligand 1 therapy response of triple‐negative breast cancer |
| title_fullStr | Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti‐programmed death receptor ligand 1 therapy response of triple‐negative breast cancer |
| title_full_unstemmed | Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti‐programmed death receptor ligand 1 therapy response of triple‐negative breast cancer |
| title_short | Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti‐programmed death receptor ligand 1 therapy response of triple‐negative breast cancer |
| title_sort | targeting ras guanyl releasing protein 1 promotes t lymphocytes infiltrations and improves anti‐programmed death receptor ligand 1 therapy response of triple‐negative breast cancer |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352603/ https://www.ncbi.nlm.nih.gov/pubmed/37461253 http://dx.doi.org/10.1002/ctm2.1335 |
| work_keys_str_mv | AT chenxi targetingrasguanylreleasingprotein1promotestlymphocytesinfiltrationsandimprovesantiprogrammeddeathreceptorligand1therapyresponseoftriplenegativebreastcancer AT yanyuanliang targetingrasguanylreleasingprotein1promotestlymphocytesinfiltrationsandimprovesantiprogrammeddeathreceptorligand1therapyresponseoftriplenegativebreastcancer AT liuwangrui targetingrasguanylreleasingprotein1promotestlymphocytesinfiltrationsandimprovesantiprogrammeddeathreceptorligand1therapyresponseoftriplenegativebreastcancer AT liuyuanhong targetingrasguanylreleasingprotein1promotestlymphocytesinfiltrationsandimprovesantiprogrammeddeathreceptorligand1therapyresponseoftriplenegativebreastcancer AT thakurabhimanyu targetingrasguanylreleasingprotein1promotestlymphocytesinfiltrationsandimprovesantiprogrammeddeathreceptorligand1therapyresponseoftriplenegativebreastcancer AT liangqiuju targetingrasguanylreleasingprotein1promotestlymphocytesinfiltrationsandimprovesantiprogrammeddeathreceptorligand1therapyresponseoftriplenegativebreastcancer AT xuzhijie targetingrasguanylreleasingprotein1promotestlymphocytesinfiltrationsandimprovesantiprogrammeddeathreceptorligand1therapyresponseoftriplenegativebreastcancer |